FDA clears second bivalent COVID-19 booster in older adults, immunocompromised patients
The Washington Post (4/18, McGinley, Sun) reports that the FDA “cleared the way for people who are at least 65 years old or immune-compromised to receive a second updated booster shot against the coronavirus, an option designed to bolster protection for the most vulnerable Americans even as the pandemic recedes.” This “bivalent booster…targets Omicron subvariants […]
